Clinical Trial Update: Study of Roxadustat (FG-4592) in Participants With End-Stage Renal Disease Receiving Maintenance Hemodialysis [Phase 2]

View source ↗

Summary

Phase 2 study of Roxadustat (FG-4592) in patients with end-stage renal disease on maintenance hemodialysis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• End-stage Renal Disease

Drugs mentioned

• Roxadustat (roxadustat)

Snippet

Sponsor: Kyntra Bio | Conditions: End Stage Renal Disease, Anemia | Phase 2 | Status: COMPLETED | Results posted: 2022-01-11